Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by diadon1945on Feb 04, 2009 2:02pm
503 Views
Post# 15751908

Thanks for all your work rjc!!!

Thanks for all your work rjc!!!It is all good news and the share price goes down!  All investors have a self interest but in the biotech area it is also gratifying to see some of the exciting medical breakthroughs that may indeed help us but also many others! 
      Stroke, TBI and MS are 3 very serious heath issues that are very poorly served by the present courses of treatment. Encouraging the brain to repair itself  by utilizing a persons own stem cells is a brilliant breakthrough and years ahead of other stem cell strategies.
     This is great science and will probably be a great investment over the next 6 months to a year. Best wishes to all.
Bullboard Posts